Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction

Abstract

Protection of renal function, adequate bladder capacity and low detrusor pressure can be achieved using supratrigonal cystectomy and augmentation ileocystoplasty in patients suffering from refractory NLUTD.

A real‐world experience with augmentation enterocystoplasty—High patient satisfaction with high complication rates

“…Bowel dysfunctions including malabsorption, diarrhea, flatulence, fecal urgency, and incontinence have been observed in more than 50% of patients with NLTUD after AE. Troublesome diarrhea may occur in up to 25‐50% of patients and adhesive small bowel obstruction has been reported to occur in 3‐6% of patients . In our study, 21.5% of the patient suffered from chronic diarrhea; only one patient had an adhesive bowel obstruction requiring surgical intervention.…”

“…Although the incidence of bladder malignancy after AE is not high, patients who had undergone AE should be regularly followed up for the rest of their lives, especially when recurrent UTI or hematuria have occurred. Routine cystoscopic surveillance was recommended 10 years postoperatively for early malignancies . We suggest annual follow‐up with renal and bladder sonography at least.…”

“…These lower urinary tract complications can lead to hydronephrosis, urinary tract infection (UTI), and renal function impairment. The main goal of bladder management in these patients is to achieve low urine storage and voiding pressure, in order to protect renal function …”

“…The main goal of bladder management in these patients is to achieve low urine storage and voiding pressure, in order to protect renal function. 1,2 Augmentation enterocystoplasty (AE) is indicated in patients with reduced bladder capacity and compliance due to NLUTD, tuberculosis, radiation cystitis, or ulcer type interstitial cystitis. 3 The procedure has been used to treat bladder dysfunction for more than 100 years and much of our knowledge about related complications comes from pediatric patients with myelomeningocele (MMC).…”

Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity

“…However, augmentation cystoplasty is a major reconstructive surgery with significant immediate and long-term morbidity. 7,8 …”